APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 70 filers reported holding APREA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,000 | -100.0% | 200 | -100.0% | 0.00% | -100.0% |
Q4 2020 | $6,206,000 | -91.8% | 1,261,285 | -60.1% | 0.00% | -87.5% |
Q3 2020 | $76,029,000 | -37.9% | 3,159,941 | +0.1% | 0.01% | -38.5% |
Q2 2020 | $122,475,000 | +16.4% | 3,158,207 | +4.4% | 0.01% | -13.3% |
Q1 2020 | $105,199,000 | +7.0% | 3,026,452 | +41.3% | 0.02% | +36.4% |
Q4 2019 | $98,316,000 | – | 2,142,428 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 1,377,654 | $6,778,000 | 2.28% |
Versant Venture Management, LLC | 1,426,328 | $7,018,000 | 0.73% |
COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $206,000 | 0.38% |
Redmile Group, LLC | 1,268,718 | $6,242,000 | 0.08% |
Gyon Technologies Capital Management, LP | 41,801 | $206,000 | 0.07% |
SECTORAL ASSET MANAGEMENT INC | 163,681 | $805,000 | 0.06% |
Palo Alto Investors LP | 128,770 | $634,000 | 0.03% |
Walleye Capital LLC | 100,800 | $496,000 | 0.03% |
Virtus ETF Advisers LLC | 10,261 | $50,000 | 0.02% |
Candriam S.C.A. | 362,346 | $1,783,000 | 0.01% |